↓ Skip to main content

Potential role of daratumumab in the treatment of multiple myeloma

Overview of attention for article published in OncoTargets and therapy, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
6 patents

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential role of daratumumab in the treatment of multiple myeloma
Published in
OncoTargets and therapy, June 2014
DOI 10.2147/ott.s49480
Pubmed ID
Authors

Yulian Khagi, Tomer M Mark

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
United States 1 2%
Unknown 50 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 23%
Student > Ph. D. Student 9 17%
Student > Master 8 15%
Other 7 13%
Student > Bachelor 4 8%
Other 3 6%
Unknown 9 17%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Agricultural and Biological Sciences 8 15%
Biochemistry, Genetics and Molecular Biology 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Psychology 3 6%
Other 7 13%
Unknown 11 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2023.
All research outputs
#4,822,596
of 25,380,192 outputs
Outputs from OncoTargets and therapy
#217
of 3,013 outputs
Outputs of similar age
#44,142
of 238,657 outputs
Outputs of similar age from OncoTargets and therapy
#6
of 24 outputs
Altmetric has tracked 25,380,192 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,657 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.